The FDA today approved sirolimus, the first drug to treat lymphangioleiomyomatosis, a rare lung disease.
Barrett’s esophagus (BE) is a serious gastrointestinal condition in which acid reflux predisposes the esophagus to increased cell proliferation and decreased apoptosis.
ZS Pharma is requesting FDA approval for sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
Patients remain largely uninformed about the dangers of unnecessary disease screening and overdiagnosis.
The FDA today approved eluxadoline and rifaximin to treat irritable bowel syndrome with diarrhea.